On Monday, the Truveris National Drug Index released its first full year figures. In 2014, generic and specialty drugs combined rising 10.9%. Brand drug prices spiked 14.8%, while specialty drug prices jumped 9.7%. Generics, historically intended to curb costs, are contributing to prescription price inflation, increasing 4.9% last year.
Prices rose across all therapeutic classes, the Index reported, but certain conditions fared worse than others. Across composite calculations of brand, generic and specialty drugs, notable rises included: muscle pain and stiffness (29.8%); inflammation (26.6%); Chronic Obstructive Pulmonary Disease (23.0%); and heart disease (19.4%).Read more